Pretomanid

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 415 publications

Annual progress in chemotherapy for tuberculosis in 2025

Annual progress in chemotherapy for tuberculosis in 2025

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases

Published: March 30, 2026

Update on Tuberculosis Treatment and Drug Regimens.

Update on Tuberculosis Treatment and Drug Regimens.

Journal: Cold Spring Harbor perspectives in medicine

Published: March 30, 2026

Exposure-QTc modeling of bedaquiline, pretomanid, and clofazimine in adults with tuberculosis.

Exposure-QTc modeling of bedaquiline, pretomanid, and clofazimine in adults with tuberculosis.

Journal: Antimicrobial agents and chemotherapy

Published: March 09, 2026

Advancing global health access through market shaping: Cases and learnings.

Advancing global health access through market shaping: Cases and learnings.

Journal: PLOS global public health

Published: February 24, 2026

Menaquinone depletion resensitises bedaquiline-resistant tuberculosis.

Menaquinone depletion resensitises bedaquiline-resistant tuberculosis.

Journal: bioRxiv : the preprint server for biology

Published: February 23, 2026

Predicting early bactericidal activity of tuberculosis drug combinations using a translational pharmacokinetic-pharmacodynamic modeling approach.

Predicting early bactericidal activity of tuberculosis drug combinations using a translational pharmacokinetic-pharmacodynamic modeling approach.

Journal: bioRxiv : the preprint server for biology

Published: February 12, 2026

Enhanced In Vitro Stability of Bedaquiline with Ascorbic Acid and Pyruvate During Long-Term Incubation in Mycobacterium Species.

Enhanced In Vitro Stability of Bedaquiline with Ascorbic Acid and Pyruvate During Long-Term Incubation in Mycobacterium Species.

Journal: Antibiotics (Basel, Switzerland)

Published: January 28, 2026

Safety pharmacology and toxicology of a novel nitroimidazooxazole antitubercular agent in SD rat and Beagle dogs.

Safety pharmacology and toxicology of a novel nitroimidazooxazole antitubercular agent in SD rat and Beagle dogs.

Journal: Molecular biomedicine

Published: January 20, 2026

Tuberculosis diagnosis and the complete drug resistance pattern from a single sample within a single day by use of a composite platform of MAX MDR-TB and AmPORE-TB.

Tuberculosis diagnosis and the complete drug resistance pattern from a single sample within a single day by use of a composite platform of MAX MDR-TB and AmPORE-TB.

Journal: Journal of clinical microbiology

Published: January 12, 2026

Same class, different activity: Delamanid and pretomanid have comparable bactericidal activity but pretomanid potently inhibits Mycobacterium tuberculosis ribosomal rRNA synthesis.

Same class, different activity: Delamanid and pretomanid have comparable bactericidal activity but pretomanid potently inhibits Mycobacterium tuberculosis ribosomal rRNA synthesis.

Journal: bioRxiv : the preprint server for biology

Published: January 09, 2026

The power of resistance: mechanisms of antimicrobial resistance in Mycobacterium tuberculosis and its impact on tuberculosis management.

The power of resistance: mechanisms of antimicrobial resistance in Mycobacterium tuberculosis and its impact on tuberculosis management.

Journal: Clinical microbiology reviews

Published: January 07, 2026

Pretomanid: The life-saving drug to combat Pakistan's TB crisis.

Pretomanid: The life-saving drug to combat Pakistan's TB crisis.

Journal: JPMA. The Journal of the Pakistan Medical Association

Published: December 11, 2025

Showing 1-12 of 415

Last Updated: 04/28/2026